Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study
Launched by GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER · Nov 14, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Offspring Born to Mothers with Polycystic Ovary Syndrome in Guangzhou Cohort study (PCOS-BIG) is a research project aimed at understanding how being exposed to a mother's condition called Polycystic Ovary Syndrome (PCOS) during pregnancy can affect a child's health both in the short term and as they grow older. Researchers in Guangzhou, China, are collecting information about the mothers, such as their health, diet, and education, as well as samples like blood and tissue from the children to see how these factors influence health later in life.
To participate in this study, children must be born to mothers who have been diagnosed with PCOS and who are planning to give birth at the Guangzhou Women and Children's Medical Center. There are no specific exclusions, so it’s open to all children born to these mothers. If eligible, families can expect to provide health information and biological samples as part of the research, helping scientists learn more about the impact of PCOS on the next generation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Offspring born to women diagnosed with PCOS
- • Offspring born to women with \<20 weeks of gestation, intended to eventually deliver in Guangzhou Women and Children's Medical Center
- • Permanent residents or families intended to remain in Guangzhou for ≥3 years
- Exclusion Criteria:
- • None
About Guangzhou Women And Children's Medical Center
Guangzhou Women and Children's Medical Center is a leading healthcare institution dedicated to advancing the health and well-being of women and children through comprehensive medical services, research, and education. As a prominent clinical trial sponsor, the center focuses on innovative studies aimed at improving maternal and pediatric health outcomes. With a commitment to evidence-based practices and collaborative partnerships, the center strives to contribute to the global body of medical knowledge while ensuring the highest standards of patient care and ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Xiu Qiu, PhD
Principal Investigator
Guangzhou Women and Children's Medical Center, China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials